BioLife Solutions

Bothell, WA-based BioLife Solutions, Inc. (NASDAQ: BLFS), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Company Growth (employees)
Type
Public
HQ
Bothell, US
Founded
1987
Size (employees)
43 (est)
BioLife Solutions was founded in 1987 and is headquartered in Bothell, US

BioLife Solutions Office Locations

BioLife Solutions has an office in Bothell
Bothell, US (HQ)
310 3303 Monte Villa Pkwy

BioLife Solutions Data and Metrics

BioLife Solutions Financial Metrics

BioLife Solutions's revenue was reported to be $6.4 m in FY, 2015 which is a 4% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2015)

6.4 m

Revenue growth (FY, 2014 - FY, 2015), %

4%

Gross profit (FY, 2015)

3.8 m

Gross profit margin (FY, 2015), %

59%

Net income (FY, 2015)

(5 m)

EBIT (FY, 2015)

(5 m)

Market capitalization (26-May-2017)

29.9 m

Closing share price (26-May-2017)

2.3

Cash (31-Dec-2016)

1.4 m
BioLife Solutions's current market capitalization is $29.9 m.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015

Revenue

8.9 m6.2 m6.4 m

Revenue growth, %

(31%)4%

Cost of goods sold

5.2 m3.2 m

Gross profit

3.8 m3 m3.8 m

Gross profit Margin, %

42%49%59%

Operating expense total

4 m6.2 m8.8 m

EBIT

(285.4 k)(3.1 m)(5 m)

EBIT margin, %

(3%)(51%)(78%)

Interest expense

742.2 k177.3 k

Interest income

20.8 k

Net Income

(1.1 m)(3.3 m)(5 m)
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.2 m1.4 m

Accounts Receivable

Inventories

1.8 m1.8 m

Current Assets

7 m4.6 m

Total Assets

12.4 m7.9 m

Accounts Payable

1 m710.7 k

Current Liabilities

1.7 m1.1 m

Additional Paid-in Capital

72.8 m74.4 m

Retained Earnings

(64.3 m)(71.2 m)

Total Equity

9.9 m3.2 m

Financial Leverage

1.3 x2.5 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(1.1 m)(3.3 m)(5 m)(8 m)

Depreciation and Amortization

343.2 k368.1 k

Accounts Receivable

Inventories

(869.4 k)(290.8 k)

Accounts Payable

194.4 k233.5 k

Cash From Operating Activities

(40.2 k)2.4 m(5 m)(4.3 m)

Purchases of PP&E

(134 k)(143.5 k)

Cash From Investing Activities

4.2 m392.8 k

Cash From Financing Activities

3.2 m
Y, 2016

Financial Leverage

2.5 x

BioLife Solutions Market Value History

BioLife Solutions Online and Social Media Presence

BioLife Solutions Company Life and Culture

You may also be interested in